ArticleScience advances2026
Uncovering simultaneous breakthroughs with a robust measure of disruptiveness.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CrossDI: A comprehensive dataset crossing three databases for calculating disruption indexes.Scientific data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progress in science and technology is punctuated by disruptive innovation and breakthroughs. To understand disruptive innovations and their drivers, the ability to operationalize and estimate "disruptiveness" is critical. Yet, this task remains difficult because scientific influence propagates through both direct and indirect citation paths, and discoveries are often fragmented across multiple papers. Here, we introduce an embedding-based metric of disruptiveness. When applied to large-scale publication data, the measure not only reliably identifies canonical breakthroughs, such as Nobel Prize-winning papers, but also finds simultaneous disruptions that eluded standard approaches. By enabling more robust identification of disruptive innovations and simultaneous discoveries, our method facilitates more accurate attribution of transformative contributions while providing insights into the mechanisms driving scientific breakthroughs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.